Myriam Bouchard
Papers
1
Total Citations
33
H-Index
1
About
Myriam Bouchard is a leading radiation oncologist whose research focuses on advancing stereotactic body radiotherapy (SBRT) for lung cancer, with a particular emphasis on patient-adapted treatment strategies. Her most cited work, "Excellent Cancer Outcomes Following Patient-adapted Robotic Lung SBRT But a Case for Caution in Idiopathic Pulmonary Fibrosis" (2014, 33 citations), demonstrates her dual commitment to optimizing cancer control while rigorously assessing patient safety. In this landmark retrospective study of 150 patients with early-stage non-small cell lung cancer, Bouchard showed that Cyberknife SBRT yields excellent outcomes when tailored to individual anatomy and tumor characteristics. Critically, she also identified that patients with idiopathic pulmonary fibrosis face elevated toxicity risks, establishing a vital cautionary principle that has shaped clinical guidelines. This work exemplifies her broader contributions to personalizing radiotherapy—balancing aggressive tumor treatment with careful risk stratification for vulnerable populations. Bouchard’s research has directly influenced how radiation oncologists approach lung SBRT, particularly in complex cases, and her findings continue to inform patient selection and treatment planning protocols worldwide. Her career reflects a dedication to evidence-based innovation that improves both survival and quality of life for cancer patients.
Research Focus
Key Achievements
Top Papers
- 1